Nitin Chandola*, C.B Pandey, Shashank Pandey and Yogendra Singh
The absence of a prehospital 12-lead electrocardiogram can cause definitive treatment delay and repeated transfer. There are already a number of wearable devices that can additionally record a lead electrocardiogram (ECG) and it is reasonable to expect this technology to become a standard feature, as is already the case with automated heart rate tracking. This could potentially have an enormous impact on the early diagnosis of several cardiac diseases. We present this case of a 30-year-old man who was diagnosed with a ventricular tachycardia episode. After the patient was hospitalized, amiodarone treatment caused his ventricular tachycardia to return to NSR. The results of a subsequent 2D-ECHO suggested cardiac sarcoidosis and showed the characteristic patterns of global longitudinal strain patterns and localized wall motion abnormalities. A rise in ACE levels was also detected. The patient had an Automatic Implantable CardioverterDefibrillator (AICD) placed after the device consistently recognized bouts of ventricular tachycardia despite optimal medical care. Later, the ECG performed was suggestive of Wide QRS determining of VT (LBBB Type) that depicted the monomorphic pattern on the graph. After the AICD was implanted, the patient underwent routine follow-up using a 12-lead smartphone-based ECG. The device's report for follow-up reveals a normal ECG rhythm. While the potential of ECG recordings by devices to detect ventricular tachycardia is currently under scientific investigation, this case highlights the possible potential of these devices to detect ventricular tachycardia.
